Neuropsychiatric Disease and Treatment (ISSN 1178-2021) is an open-access journal published by Taylor & Francis in the United Kingdom. It covers Medicine, Neuroscience, Psychiatry and Mental Health and Biological Psychiatry. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 3.2, Scopus Q2, Web of Science Q2, CiteScore 5.3 and HEC W-Category. Article processing charge: USD 3,940. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Neuropsychiatric Disease and Treatment
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q2 journals · HEC W category journals · Scopus journals · Web of Science journals · PubMed journals · DOAJ journals · SCImago journals · SCIE journals · Impact factor journals · Open access journals · Q2 Medicine journals · Q2 Neuroscience journals
Quick answers about Neuropsychiatric Disease and Treatment
Is Neuropsychiatric Disease and Treatment HEC recognised?
Yes. The catalogue records Neuropsychiatric Disease and Treatment in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Neuropsychiatric Disease and Treatment indexed in Scopus?
Yes. Neuropsychiatric Disease and Treatment is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 5.3. Check its current status on the Scopus Sources page.
Is Neuropsychiatric Disease and Treatment in Web of Science?
Yes. Neuropsychiatric Disease and Treatment is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.
What is the impact factor of Neuropsychiatric Disease and Treatment?
The recorded journal impact factor of Neuropsychiatric Disease and Treatment is 3.2. Clarivate updates impact factors every year in Journal Citation Reports.
Is Neuropsychiatric Disease and Treatment open access, and what does it charge?
Neuropsychiatric Disease and Treatment is an open-access journal and its APC is USD 3,940. Fees change, so check the journal's website before you submit.
How long does Neuropsychiatric Disease and Treatment take to publish?
The recorded average time from submission to publication is about 16 weeks. Individual papers can take longer, especially when revisions are requested.
Who publishes Neuropsychiatric Disease and Treatment?
Neuropsychiatric Disease and Treatment is published by Taylor & Francis in United Kingdom, under ISSN 1178-2021.
Research profile
- 4,769articles indexed
- 152,113citations
- 138h-index
- 4.092-year mean citedness
- 1971first year indexed
Main research topics: Schizophrenia research and treatment, Treatment of Major Depression, Dementia and Cognitive Impairment Research, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Bipolar Disorder and Treatment, Mental Health Treatment and Access.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Medicine journals (8,023)
- Neuroscience journals (681)
- Psychiatry and Mental Health journals (612)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in DOAJ (10,243)
- Journals indexed in HEC (34,823)
- Scopus Q2 journals (8,223)
- Web of Science Q2 journals (5,019)
- HEC W-Category journals (13,616)
- Journals published in the United Kingdom (7,333)
- Taylor & Francis journals (2,448)